Prospective Multicenter Real-world Study of Surufatinib in Patients With Advanced Neuroendocrine Neoplasms

Clinical trial NCT07272512 · RECRUITING

Trial details

NCT number: NCT07272512
Sponsor: Shanghai Zhongshan Hospital
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Neuroendocrine Tumors Neuroendocrine Neoplasms

Start date: 2025-11-11
Primary completion: 2027-11-29
Enrollment: 350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.